Catalog Technologies is a DNA-based data storage and computing company founded by MIT scientists. The company develops synthetic DNA technology to encode, store, and compute digital data, offering a sustainable alternative to traditional data storage with potential for long-term archival (1,000+ years) and massive parallel computation capabilities.
Catalog (Biotechnology) has been acquired
This company is no longer available on our private secondary market.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2016
Employees
11–50
Total Funding
$55.5M
4 rounds
Total raised $55.5M across 4 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Last updated 06-25-2026
Latest Round
Type
Series B
Date
September 30, 2021
Amount
$35M
Valuation
—
Lead Investors
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| September 30, 2021 | Series B | $35M | — | Hanwha Impact |
| September 8, 2020 | Series A | $10M | — | Horizons Ventures |
| October 2018 | Seed (early) | $1.5M | — | Not disclosed |
Hyunjun Park
Co-founder & CEO
Nathaniel Roquet
Co-founder & Chief Technology Officer
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Biomemory
French DNA data storage company that acquired Catalog Technologies; specializes in enzymatic DNA synthesis for secure data storage.
DNA Script
DNA synthesis company developing programmable DNA printers for synthetic biology and data storage applications.
Intrexon (now Precigen)
Synthetic biology company working on DNA-based solutions for agriculture, healthcare, and data storage.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.